- Home
- PTLO vs IMTX Comparison
PTLO vs IMTX Comparison
Compare PTLO & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTLO
- IMTX
- Stock Information
- Founded
- PTLO 1963
- IMTX N/A
- Country
- PTLO United States
- IMTX Germany
- Employees
- PTLO N/A
- IMTX N/A
- Industry
- PTLO Restaurants
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PTLO Consumer Discretionary
- IMTX Health Care
- Exchange
- PTLO Nasdaq
- IMTX Nasdaq
- Market Cap
- PTLO 670.4M
- IMTX 579.8M
- IPO Year
- PTLO 2021
- IMTX N/A
- Fundamental
- Price
- PTLO $13.35
- IMTX $4.74
- Analyst Decision
- PTLO Buy
- IMTX Strong Buy
- Analyst Count
- PTLO 7
- IMTX 4
- Target Price
- PTLO $13.86
- IMTX $16.67
- AVG Volume (30 Days)
- PTLO 2.1M
- IMTX 496.3K
- Earning Date
- PTLO 05-06-2025
- IMTX 05-13-2025
- Dividend Yield
- PTLO N/A
- IMTX N/A
- EPS Growth
- PTLO 8.11
- IMTX N/A
- EPS
- PTLO 0.43
- IMTX N/A
- Revenue
- PTLO $721,160,000.00
- IMTX $155,801,989.00
- Revenue This Year
- PTLO $12.37
- IMTX N/A
- Revenue Next Year
- PTLO $14.01
- IMTX $4.92
- P/E Ratio
- PTLO $31.35
- IMTX N/A
- Revenue Growth
- PTLO 4.57
- IMTX 93.56
- 52 Week Low
- PTLO $8.38
- IMTX $3.30
- 52 Week High
- PTLO $15.78
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- PTLO 71.89
- IMTX 64.53
- Support Level
- PTLO $11.00
- IMTX $4.15
- Resistance Level
- PTLO $11.57
- IMTX $4.83
- Average True Range (ATR)
- PTLO 0.59
- IMTX 0.42
- MACD
- PTLO 0.34
- IMTX 0.07
- Stochastic Oscillator
- PTLO 94.81
- IMTX 98.65
About PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.